Literature DB >> 23303142

Anal versus rectal melanoma: does site of origin predict outcome?

Danielle M Bello1, Elizabeth Smyth, Daniel Perez, Shaheer Khan, Larissa K Temple, Charlotte E Ariyan, Martin R Weiser, Richard D Carvajal.   

Abstract

BACKGROUND: Anatomic site is a predictive factor in subtypes of cutaneous and mucosal melanoma.
OBJECTIVE: The aim of this study was to examine the clinical relevance of location of origin of anorectal melanoma as a prognostic factor.
DESIGN: With the use of a prospectively maintained database, clinical characteristics, management, and outcomes were compared according to the site of origin. SETTINGS, PATIENTS,
INTERVENTIONS: A retrospective review was conducted of patients diagnosed with anorectal melanoma from 1994 to 2010. Tumors were defined as anal, anorectal, or rectal melanoma according to their anatomic relationship to the dentate line. MAIN OUTCOME MEASURES: Clinicopathologic factors were compared by χ2 test. Time-to-event analysis was performed by Kaplan-Meier analysis.
RESULTS: Of the 96 patients included (41 with anal melanoma, 32 with anorectal melanoma, 23 with rectal melanoma), patients with rectal and anorectal mucosal melanoma had advanced primary tumors (median Breslow thickness, 12 mm and 8 mm, p = 0.002), whereas anal lesions could be found at earlier depths (median thickness, 6.5 mm). Patients with anal tumors more commonly underwent transanal excision (p < 0.02) and sentinel lymph node biopsy (p = 0.004) versus anorectal and rectal tumors. Patterns of recurrence were also distinct; nearly two-thirds of anorectal and rectal tumors recurred systemically, whereas anal melanoma more often recurred within the lymph nodes first (63%; p < 0.02). Recurrence occurred in 24 (59%) patients with anal tumors, 23 (72%) patients with anorectal tumors, and 16 (70%) patients with rectal tumors. Median overall survival was 22 months for anal melanoma, 28 months for anorectal melanoma, and 27 months for rectal melanoma. Recurrence and survival were not statistically different between the groups. LIMITATIONS: This study is limited by small sample size and its retrospective nature.
CONCLUSIONS: This study represents the only series describing the outcomes of anorectal melanoma by anatomic location. Lesions at or proximal to the dentate line present with more advanced disease, possibly related to a delay in diagnosis. Lesions distal to the dentate line more commonly recur within lymph nodes, which may represent differences in nodal drainage. Irrespective of location, the long-term prognosis remains poor for all cases of anorectal melanoma.

Entities:  

Mesh:

Year:  2013        PMID: 23303142      PMCID: PMC3543771          DOI: 10.1097/DCR.0b013e31827901dd

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  25 in total

1.  Melanoma survival in the United States, 1992 to 2005.

Authors:  Lori A Pollack; Jun Li; Zahava Berkowitz; Hannah K Weir; Xiao-Cheng Wu; Umed A Ajani; Donatus U Ekwueme; Chunyu Li; Brian P Pollack
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

3.  Anorectal melanoma--an incurable disease?

Authors:  C Thibault; P Sagar; S Nivatvongs; D M Ilstrup; B G Wolff
Journal:  Dis Colon Rectum       Date:  1997-06       Impact factor: 4.585

Review 4.  Mucosal melanoma: a clinically and biologically unique disease entity.

Authors:  Richard D Carvajal; Sharon A Spencer; William Lydiatt
Journal:  J Natl Compr Canc Netw       Date:  2012-03       Impact factor: 11.908

5.  KIT as a therapeutic target in metastatic melanoma.

Authors:  Richard D Carvajal; Cristina R Antonescu; Jedd D Wolchok; Paul B Chapman; Ruth-Ann Roman; Jerrold Teitcher; Katherine S Panageas; Klaus J Busam; Bartosz Chmielowski; Jose Lutzky; Anna C Pavlick; Anne Fusco; Lauren Cane; Naoko Takebe; Swapna Vemula; Nancy Bouvier; Boris C Bastian; Gary K Schwartz
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

6.  Changing epidemiology of anorectal melanoma.

Authors:  B Cagir; M H Whiteford; A Topham; J Rakinic; R D Fry
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

7.  KIT pathway alterations in mucosal melanomas of the vulva and other sites.

Authors:  Katarina Omholt; Eva Grafström; Lena Kanter-Lewensohn; Johan Hansson; Boel K Ragnarsson-Olding
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

8.  c-kit gene mutation and CD117 expression in human anorectal melanomas.

Authors:  Shujuan Ni; Dan Huang; Xiaochen Chen; Jiaying Huang; Yunyi Kong; Ye Xu; Xiang Du; Weiqi Sheng
Journal:  Hum Pathol       Date:  2011-12-09       Impact factor: 3.466

9.  The role of abdominoperineal resection as surgical therapy for anorectal melanoma.

Authors:  Jen Jen Yeh; Jinru Shia; Wen Jen Hwu; Klaus J Busam; Philip B Paty; Jose G Guillem; Daniel G Coit; W Douglas Wong; Martin R Weiser
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

10.  A comparison of wide local excision with abdominoperineal resection in anorectal melanoma.

Authors:  Lok B Yap; Paul Neary
Journal:  Melanoma Res       Date:  2004-04       Impact factor: 3.599

View more
  16 in total

1.  Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.

Authors:  So-Woon Kim; Young Il Kim; Bilal Mustafa; Mi-Ju Kim; Gowun Jeong; Sung-Min Ahn; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim; Seung-Mo Hong; In Ja Park
Journal:  Mod Pathol       Date:  2020-07-24       Impact factor: 7.842

2.  Patterns of Care and Survival Outcomes in the Treatment of Anal Melanoma.

Authors:  Jaffer Naqvi; Anna Lee; Ariel Lederman; Ami Kavi; Virginia W Osborn; David Schreiber
Journal:  J Gastrointest Cancer       Date:  2020-03

3.  Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution.

Authors:  Isália Miguel; João Freire; Maria José Passos; António Moreira
Journal:  Med Oncol       Date:  2014-12-13       Impact factor: 3.064

Review 4.  Beyond adenocarcinoma: MRI of uncommon rectal neoplasms and mimickers.

Authors:  David D B Bates; Maria Clara Fernandes de Paula; Natally Horvat; Shannon Sheedy; Chandana Lall; Zahra Kassam; Perry Pickhardt; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2019-11

Review 5.  Premalignant and Malignant Perianal Lesions.

Authors:  Mohammad Ali Abbass; Michael A Valente
Journal:  Clin Colon Rectal Surg       Date:  2019-08-22

6.  Unexpected post-operative diagnosis of primary rectal melanoma. A case report.

Authors:  E Erdas; P G Calò; S Licheri; M Pomata
Journal:  G Chir       Date:  2014 May-Jun

7.  Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.

Authors:  Priyadharsini Nagarajan; Jin Piao; Jing Ning; Laura E Noordenbos; Jonathan L Curry; Carlos A Torres-Cabala; A Hafeez Diwan; Doina Ivan; Phyu P Aung; Merrick I Ross; Richard E Royal; Jennifer A Wargo; Wei-Lien Wang; Rashmi Samdani; Alexander J Lazar; Asif Rashid; Michael A Davies; Victor G Prieto; Jeffrey E Gershenwald; Michael T Tetzlaff
Journal:  Mod Pathol       Date:  2019-08-05       Impact factor: 7.842

8.  Anorectal Mucosal Melanoma in the Era of Immune Checkpoint Inhibition: Should We Change Our Surgical Management Paradigm?

Authors:  Mohammad Adileh; Jonathan B Yuval; Shan Huang; Alexander N Shoushtari; Felipe Quezada-Diaz; Emmanouil P Pappou; Martin R Weiser; Julio Garcia-Aguilar; J Joshua Smith; Philip B Paty; Garrett M Nash
Journal:  Dis Colon Rectum       Date:  2021-05       Impact factor: 4.585

9.  Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era.

Authors:  Dai Ogata; Keita Tsutsui; Kenjiro Namikawa; Konosuke Moritani; Kenta Nakama; Shunichi Jinnai; Akira Takahashi; Shunsuke Tsukamoto; Yukihide Kanemitsu; Naoya Yamazaki
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-03       Impact factor: 4.553

10.  Genetic alteration of Chinese patients with rectal mucosal melanoma.

Authors:  Huan Li; Lujing Yang; Yumei Lai; Xintong Wang; Xinyin Han; Siyao Liu; Dongliang Wang; Xiaojuan Li; Nana Hu; Yan Kong; Lu Si; Zhongwu Li
Journal:  BMC Cancer       Date:  2021-05-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.